19.09.2018
- Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
20.07.2017
- The European Commission has accused Israeli drugmaker Teva and its US subsidiary Cephalon of breaching antitrust rules. Regulators classed an agreement between the companies to...
06.04.2017
- Within two days, one of the three mega mergers influencing in major part the agrochemicals sector moved two steps closer to becoming reality. On Apr. 4-5, the US Federal Trade...
22.02.2017
- Chinese drugmaker Qilu Pharmaceutical has introduced a new targeted therapy generic cancer medicine, geftinib, which is claimed to be effective against non-small cell lung cancer...
07.02.2017
- US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...
31.01.2017
- US company Barr Laboratories, a subsidiary of Israeli drugmaker Teva, has reached a $225 million settlement in an antitrust class action that accused Teva of keeping a generic...
